Home NDC 0093-3242 bisoprolol fumarate and hydrochlorothiazide
Product NDC 0093-3242
11-digit product format 000933242
Labeler code 0093
Product ID 0093-3242_26f2531b-2b5e-46a5-9a31-fa7cd89ef8b2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name bisoprolol fumarate and hydrochlorothiazide
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application NDA020186
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2019-08-07
Substance BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Active strength 5; 6.25 mg/1; mg/1
Pharmacologic classes Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 0093-3242 UNFINISHED Active or certified unfinished drug listing 2026-10-05 unfinished package package 0093-3242 0093-3242-99 UNFINISHED Active or certified unfinished drug listing 2026-10-05
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 0093-3242-99 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 0093-3242-99 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 0093-3242-99 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 0093-3242-99 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 0093-3242-99 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 0093-3242-99 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 0093-3242-99 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 0093-3242-99 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 0093-3242-99 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 0093-3242-99 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 0093-3242-99 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 0093-3242-99 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 0093-3242-99 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 0093-3242-99 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 unfinished product product 906f6e251498…bf70b80e44f0…2022-04-09 23:13 UTC · source 2022-04-08 unfinished package package 0093-3242-99 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 unfinished product product 6db9cb8d1e19…3449e1ec5b70…2021-12-27 23:28 UTC · source 2021-12-27 unfinished package package 0093-3242-99 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 unfinished product product 8fc7167e32ce…e96bbc724034…2021-02-18 23:40 UTC · source 2021-02-18 unfinished package package 0093-3242-99 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 unfinished product product 4184dd79f89f…545327b3e20f…2020-12-18 03:04 UTC · source 2020-12-17 unfinished package package 0093-3242-99 4184dd79f89f…545327b3e20f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020186-001 ZIAC BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 N020186-002 ZIAC BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 N020186-003 ZIAC BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020186-002 ZIAC 10MG;6.25MG TABLET / ORAL AB RLD, RS 1993-03-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020186-003 ZIAC 2.5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020186-001 ZIAC 5MG;6.25MG TABLET / ORAL AB RLD 1993-03-26 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base bisoprolol fumarate and hydrochlorothiazide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BISOPROLOL FUMARATE 5 mg/1 HYDROCHLOROTHIAZIDE 6.25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0J48LPH2TH Internal UNII lookup UR59KN573L Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 854908 Internal RxNorm lookup 854916 Internal RxNorm lookup 854919 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-3242-01 bisoprolol fumarate and hydrochlorothiazide 100 in 1 BOTTLE TABLET, FILM COATED 100 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-3242 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] 13 Current NDC, Legacy NDC, 1 package rows 20250212_27d52b23-e3e2-4339-b00e-cd0fec43ffbb.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0093-3242-01 00093324201 100 TABLET, FILM COATED in 1 BOTTLE (0093-3242-01) 2019-08-07 0000-00-00 No No Current 0093-3242-99 00093324299 45845 TABLET, FILM COATED in 1 DRUM (0093-3242-99) 23-NOV-20 Current